ATTO Attovia Therapeutics, Inc.
$13.88▲ +0.36%
Healthcare
Other
Volume 224.6K
Avg Volume (10D) 418.6K
Key Metrics & Fundamentals
Market Cap
$633.64M
P/E Ratio
–
Div Yield
0.00%
52W Range
12.94 - 28.00
% vs 50 MA
-27.74%
% vs 200 MA
–%
RSI-14
31.7
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.96
Free Cash Flow
-$16.86M
Gross Rev
$450,000
Gross Profit
$450,000
EBITDA
-$21.56M
COGS
–
Operating Exp
$22.25M
Operating Income
-$21.80M
EBIT
-$21.80M
Pretax Income
-$20.69M
Net Income
-$20.69M
EPS (Diluted)
-0.48
Price & Volume History
Loading chart…
Recent News
Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026
GlobeNewswire · Sep 28, 2026 4:05 PM ET
Was Moderna Stock's Cancer Vaccine Run Visible In Advance?
Trefis · Sep 22, 2026 1:39 PM ET
Attovia Therapeutics (ATTO) Pulls Back As Investors Ask If The Valuation Still Fits
Simply Wall St. · Sep 21, 2026 11:25 PM ET
Attovia Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 3, 2026 4:05 PM ET
Attovia Therapeutics Q2 Net Loss Widens
MT Newswires · Sep 2, 2026 4:48 PM ET
Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
GlobeNewswire · Sep 2, 2026 4:05 PM ET
Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says
MT Newswires · Aug 31, 2026 11:16 AM ET
Deere upgraded, Lumentum initiated: Wall Street's top analyst calls
The Fly · Aug 31, 2026 9:45 AM ET
Here Are Monday’s Top Wall Street Analyst Research Calls: AGCO Corporation, Deere & Co., Edison International, Lumentum Holdings, PG&E, Sempra Energy, STAG Industrial, Ticketplus, and More
24/7 Wall St. · Aug 31, 2026 7:56 AM ET
Moderna Stock Carries A Market Value Its Revenue Does Not Support
Trefis · Aug 26, 2026 11:13 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ATTO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.